After completion of the phase 2 trial should spark licensing or takeover bid
Shares by next year, I couldn't tell.
Huge opportunity here, DXB could change the process of drug manufacturing saving years off research. Very possible to change the way drugs are designed/manufactured/processed. Changing history, saving millions in research and testing. One of my investor friends works in medicine and believes this is the best LT in a long time. I should get him to elaborate and post it here.
$60 Million MC by 2017, page-3
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.025(6.17%) |
Mkt cap ! $211.6M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 40.5¢ | 38.0¢ | $1.199M | 3.093M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 495495 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 121002 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |